1. From the Medical Research Council (MRC) Clinical Sciences Centre, Faculty of Medicine, Imperial College, Hammersmith Hospital Campus, London, United Kingdom; the Laboratory of Lymphocyte Signalling and Development, The Babraham Institute, Babraham, Cambridge, United Kingdom; and the Centre d'Immunologie de Marseille-Luminy, Parc Scientifique et Technologique de Luminy, Marseille, France.